BofA on Amgen (AMGN): 'Catalysts: pelacarsen readthrough shifts to mid-2026'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Amgen Inc (NASDAQ: AMGN) | Delayed: 478.48 +17.22 (3.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $461.26 | 52 Week High | $176.85 | |||
| Open | $479.61 | 52 Week Low | $133.64 | |||
| Day High | $482.48 | P/E | 72.06 | |||
| Day Low | $464.13 | EPS | $6.64 | |||
| Volume | 4,618,235 | |||||
